Fact Based List:
Highlights from AAM's Generic & Biosimilar Medicines Savings Report
Submitted by Patty Jamison on Tue, 10/24/2023 - 13:19
- Total Generic and Biosimilar Savings for 2022: $408 billion
- Total Generic and Biosimilar Savings for Past 10 years: more than $2.9 trillion
- Total Generic and Biosimilar Savings in Medicare for 2022: $130 Billion
- Total Generic and Biosimilar Savings in Commercial Plans for 2022: $194 Billion
- Generics represent 90% of prescriptions filled but only 17.5% of prescription drug spending
- Generics represent less than 2% of all health care spending
Source: AAM, Generic and Biosimilar Drugs Generate $408 Billion in Savings For America’s Patients and Health-Care System in 2022, September 6, 2023
Source URL: https://accessiblemeds.org/resources/press-releases/generic-...
List Ratings: |
Lists You Might Also Be Interested In
- YouTube Videos Corresponding to A Dozen Selected Healthcare Keywords
- eBizMBA Top 15 Most Popular Health Websites | March 2015
- PNC Healthcare: Five Ways Tech-Savvy Millennials Alter Health Care Landscape
- Population Health Advantages by Priority Rank - Stakeholder e-Poll Results
- 7 Best Practices for Developing Successful Diabetes Mobile Apps
Login or register to post comments